Meridian Bioscience Sets a New Sustainability Standard in Diagnostic Assay Development with the Launch of Two New Animal-Free Immunoassay Interference Blockers

The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of two new immunoassay interference blockers, K-Block™, and Mouse-Free IgG.

WellSky Acquires Long-Term Care EHR Experience Care – M&A

What You Should Know: WellSky, a leading health and community care technology company, announced today that it has acquired Experience Care, an innovative technology company offering

August 24, 2023

SKAN announces preliminary key figures for the 2024 financial year – Biotech Investments

SKAN AG / Key word(s): Preliminary Results 22-Jan-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

January 23, 2025

Opinion | Patients Hitting GLP-1 Plateaus? Here’s How to Help

Stanford is an internist, pediatrician, and obesity medicine physician scientist. Frank is chief medical officer of a virtual care platform. Drugs like semaglutide (Wegovy) and

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.